Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Consensus Recommendation of “Buy” by Analysts
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been assigned an average recommendation of “Buy” from the seven analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the […]
More Stories
Jane Street Group LLC Grows Stake in Gerdau S.A. (NYSE:GGB)
Jane Street Group LLC increased its holdings in Gerdau S.A. (NYSE:GGB – Free Report) by 221.1% during the fourth quarter,...
Amazon.com, Inc. (NASDAQ:AMZN) Position Decreased by First Commonwealth Financial Corp PA
First Commonwealth Financial Corp PA lessened its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 1.0% during the fourth quarter, Holdings Channel.com...
Regal Investment Advisors LLC Sells 8,509 Shares of Amazon.com, Inc. (NASDAQ:AMZN)
Regal Investment Advisors LLC lowered its position in Amazon.com, Inc. (NASDAQ:AMZN) by 16.2% in the 4th quarter, HoldingsChannel.com reports. The...
Finer Wealth Management Inc. Has $9.72 Million Stake in Amazon.com, Inc. (NASDAQ:AMZN)
Finer Wealth Management Inc. boosted its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 1.4% in the 4th quarter, according...
Avenir Corp Decreases Stock Position in Amazon.com, Inc. (NASDAQ:AMZN)
Avenir Corp decreased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 3.4% during the fourth quarter, Holdings Channel.com reports. The institutional...
Northern Trust Corp Has $23.70 Million Stock Position in Flywire Co. (NASDAQ:FLYW)
Northern Trust Corp increased its stake in shares of Flywire Co. (NASDAQ:FLYW – Free Report) by 10.3% in the fourth...